TYLER MICHAEL BONE

Allopathic & Osteopathic Physicians|Otolaryngology JONESBORO, AR NPI 1013404284

General Payments — all program years on this page

$3,987.66

  • Category: General Payments
  • Program years: PY2023–2024
  • Record count: 55
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $596.00 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $485.1919
Education $110.812

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2023 $3,391.6634
2024 $596.0021

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1114012237 Regeneron Healthcare Solutions, Inc. $26.96 02/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114012239 Regeneron Healthcare Solutions, Inc. $32.36 09/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114012241 Regeneron Healthcare Solutions, Inc. $22.57 10/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114012243 Regeneron Healthcare Solutions, Inc. $57.82 10/03/2024 Education Undisputed 01/23/2026 View at CMS
1114012245 Regeneron Healthcare Solutions, Inc. $34.55 12/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115932174 GlaxoSmithKline, LLC. $16.59 11/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116133503 GlaxoSmithKline, LLC. $15.00 02/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116499613 GlaxoSmithKline, LLC. $18.03 04/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116612173 GlaxoSmithKline, LLC. $18.60 01/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116654011 GlaxoSmithKline, LLC. $17.31 07/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117026991 Medtronic, Inc. $109.05 03/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117026993 Medtronic, Inc. $15.80 03/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119781147 Stryker Corporation $17.45 05/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1127504620 Hikma Pharmaceuticals USA $14.97 01/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139576225 GENZYME CORPORATION $15.77 01/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139576281 GENZYME CORPORATION $22.91 05/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139576337 SANOFI-AVENTIS U.S. LLC $52.99 10/03/2024 Education Undisputed 01/23/2026 View at CMS
1139576343 GENZYME CORPORATION $27.63 11/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144645895 AERIN MEDICAL INC. $20.89 07/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144649372 AERIN MEDICAL INC. $20.37 09/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144651344 AERIN MEDICAL INC. $18.38 02/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.